 Different effect benzylacyclouridine toxic therapeutic effects azidothymidine mice vitro uridine Urd azidothymidine AZT cytotoxicity anti-human immunodeficiency virus HIV activity studies mice daily oral doses benzylacyclouridine BAU inhibitor Urd breakdown AZT hematologic toxicity plasma concentration Urd murine studies effect various doses exogenous Urd various doses BAU combination BAU Urd AZT-induced toxicity mice receiving concomitant AZT daily doses Urd mg/kg increase peripheral reticulocytes AZT-induced hematologic toxicity range effective doses narrow doses Urd mg/kg/d hematologic toxicity effective dose mg/kg/d Urd mortality contrast BAU mg/kg/d AZT-related hematologic toxicity dose-dependent manner mortality daily doses BAU combination BAU low doses Urd effective mice Rauscher murine leukemia virus RLV BAU antiretroviral effect AZT doses AZT-induced anemia leukopenia findings significant treatment patients acquired immunodeficiency syndrome AIDS AIDS-related complex